MyFinsight
Home
Blog
About
Back
Cash Flow
BIOXYTRAN, INC (BIXT)
BIOXYTRAN, INC (BIXT)
source: myfinsight.com
Proceeds from stock sales
$45,346
Proceeds from warrant
issuance
$28,147
Net cash provided by
financing activities
$73,493
(-71.86%↓ Y/Y)
Net decrease in cash
-$285,663
(-14112.09%↓ Y/Y)
Canceled cashflow
$73,493
something is missing
$2,068,989
Accounts payable and
accrued expenses...
$207,639
(258.16%↑ Y/Y)
Accounts payable and
accrued expenses
$133,181
(-78.59%↓ Y/Y)
Stock-based compensation
$30,515
(-26.05%↓ Y/Y)
Amortization of ip
$5,580
(27.98%↑ Y/Y)
Net cash used in
operating activities
-$349,773
(-41.03%↓ Y/Y)
Canceled cashflow
$2,445,904
Net cash used in
investing activities
-$9,383
(38.18%↑ Y/Y)
Net income (loss)
attributable to bioxytran
-$2,688,918
Change in fv of
derivative
$106,759
(121.47%↑ Y/Y)
Investment in intangibles
$9,383
(-38.18%↓ Y/Y)
Back